{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:15Z","timestamp":1792782915961,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade De S\u00e3o Paulo","id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurocysticercosis (NCC) is the leading cause of late-onset epilepsy in endemic regions, yet long-term data on severe forms remain limited. This study analyzed temporal trends in severe NCC over three decades following mandatory notification in a high-incidence region of Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective population-based study included Neurocysticercosis cases reported from January 1995 to September 2024 in a high-incidence endemic area of S\u00e3o Paulo State, Brazil. Confirmed NCC cases were reclassified as intracranial hypertension syndrome (IHS) or other clinical presentations (epileptic, meningeal, asymptomatic). Clinical, neuroimaging, and cerebrospinal fluid data were analyzed. Multivariable logistic regression identified factors associated with severe disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 518 reported cases, 465 confirmed NCC cases were included. In the first decade (1991\u20132000,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009262), 13.4% (35\/262) were severe. Between these periods (2001\u20132010,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009125), a steady decline in total incidence was observed. In the most recent period (2011\u20132020,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200978), the proportion of severe cases rose to 65.4% (51\/78). Meningeal manifestations were associated with increased severity risk (OR\u2009=\u20092.99; 95%CI: 1.81\u20134.94), whereas epileptic (OR\u2009=\u20090.30; 95%CI: 0.18\u20130.48) and asymptomatic presentations (OR\u2009=\u20090.21; 95%CI: 0.11\u20130.40) were protective. Neurosurgical procedures were required in 79.4% of severe cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite declining overall incidence, the increasing proportion of severe NCC (intracranial hypertension) likely reflects late-stage diagnoses of long-standing infections that remained asymptomatic for decades. This trend suggests a \u2018catch-up\u2019 effect in detecting complex cases through improved neuroimaging, even as primary prevention programs successfully reduce new infections. .<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-026-05555-9","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:21:40Z","timestamp":1783383700000},"page":"3149-3158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three decades of neurocysticercosis mandatory notification in a Brazilian endemic region: clinical evolution and severity patterns"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-4898","authenticated-orcid":false,"given":"Tissiana Marques","family":"de Haes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thales Pardini","family":"Fagundes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trajano Aguiar Pires","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo Massaiti","family":"Takayanagui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"3","key":"5555_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1590\/S0037-86822001000300007","volume":"34","author":"OM Takayanagui","year":"2001","unstructured":"Takayanagui OM, Leite JP, Neurocysticercosis (2001) Rev Soc Bras Med Trop 34(3):283\u2013290. https:\/\/doi.org\/10.1590\/S0037-86822001000300007","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3","key":"5555_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archinte.1985.00360030076014","volume":"145","author":"J Sotelo","year":"1985","unstructured":"Sotelo J, Guerrero V, Rubio F (1985) Neurocysticercosis: a new classification based on active and inactive forms. Arch Intern Med 145(3):442\u2013445. https:\/\/doi.org\/10.1001\/archinte.1985.00360030076014","journal-title":"Arch Intern Med"},{"issue":"11","key":"5555_CR3","doi-asserted-by":"publisher","first-page":"e870","DOI":"10.1371\/journal.pntd.0000870","volume":"4","author":"PC Ndimubanzi","year":"2010","unstructured":"Ndimubanzi PC, Carabin H, Budke CM et al (2010) A systematic review of the frequency of neurocysticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4(11):e870. https:\/\/doi.org\/10.1371\/journal.pntd.0000870","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"5555_CR4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1086\/313470","volume":"29","author":"C Bern","year":"1999","unstructured":"Bern C, Garcia HH, Evans C et al (1999) Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29(5):1203\u20131209. https:\/\/doi.org\/10.1086\/313470","journal-title":"Clin Infect Dis"},{"issue":"10","key":"5555_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(05)70194-0","volume":"4","author":"HH Garcia","year":"2005","unstructured":"Garcia HH, Del Brutto OH (2005) Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4(10):653\u2013661. https:\/\/doi.org\/10.1016\/S1474-4422(05)70194-0","journal-title":"Lancet Neurol"},{"issue":"10","key":"5555_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2011.135","volume":"7","author":"TE Nash","year":"2011","unstructured":"Nash TE, Garcia HH (2011) Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 7(10):584\u2013594. https:\/\/doi.org\/10.1038\/nrneurol.2011.135","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"5555_CR7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.meegid.2010.08.006","volume":"10","author":"A Verma","year":"2010","unstructured":"Verma A, Prasad KN, Cheekatla SS et al (2010) Genetic polymorphism of Taenia solium metacestodes in north Indian neurocysticercosis patients. Infect Genet Evol 10(8):1220\u20131224. https:\/\/doi.org\/10.1016\/j.meegid.2010.08.006","journal-title":"Infect Genet Evol"},{"issue":"5","key":"5555_CR8","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1371\/journal.pntd.0001152","volume":"5","author":"H Carabin","year":"2011","unstructured":"Carabin H, Ndimubanzi PC, Budke CM et al (2011) Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5(5):e1152. https:\/\/doi.org\/10.1371\/journal.pntd.0001152","journal-title":"PLoS Negl Trop Dis"},{"key":"5555_CR9","doi-asserted-by":"publisher","unstructured":"Carpio A, Fleury A, Kelvin EA, Romo ML, Abraham R, Tellez-Zenteno J (2018) New guidelines for the diagnosis and treatment of neurocysticercosis: a difficult proposal for patients in endemic countries. Expert Rev Neurother 18(10):1\u20135. https:\/\/doi.org\/10.1080\/14737175.2018.1518133","DOI":"10.1080\/14737175.2018.1518133"},{"issue":"9383","key":"5555_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(03)14117-7","volume":"362","author":"HH Garc\u00eda","year":"2003","unstructured":"Garc\u00eda HH, Gonz\u00e1lez AE, Evans CA et al (2003) Taenia solium cysticercosis. Lancet 362(9383):547\u2013556. https:\/\/doi.org\/10.1016\/S0140-6736(03)14117-7","journal-title":"Lancet"},{"issue":"suppl","key":"5555_CR11","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.parint.2005.11.016","volume":"55","author":"OM Takayanagui","year":"2006","unstructured":"Takayanagui OM, Odashima NS (2006) Clinical aspects of neurocysticercosis. Parasitol Int 55(suppl):S111\u2013S115. https:\/\/doi.org\/10.1016\/j.parint.2005.11.016","journal-title":"Parasitol Int"},{"issue":"6","key":"5555_CR12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/jnnp.62.6.612","volume":"62","author":"OV Forlenza","year":"1997","unstructured":"Forlenza OV, Vieira Filho AH, Machado LR et al (1997) Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry 62(6):612\u2013616. https:\/\/doi.org\/10.1136\/jnnp.62.6.612","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2B","key":"5555_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1590\/S0004-282X2009000300012","volume":"67","author":"OM Takayanagui","year":"2009","unstructured":"Takayanagui OM (2009) Neurocysticercosis. I. Clinical study of 151 cases. Arq Neuropsiquiatr 67(2B):448\u2013456. https:\/\/doi.org\/10.1590\/S0004-282X2009000300012","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"5555_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4269\/ajtmh.20-1566","volume":"105","author":"J Abanto","year":"2021","unstructured":"Abanto J, Saavedra H, Bustos JA et al (2021) Mortality in parenchymal and subarachnoid neurocysticercosis. Am J Trop Med Hyg 105(1):176\u2013180. https:\/\/doi.org\/10.4269\/ajtmh.20-1566","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"5555_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1528-1157.1998.tb01288.x","volume":"39","author":"A Carpio","year":"1998","unstructured":"Carpio A, Escobar A, Hauser WA (1998) Cysticercosis and epilepsy: a critical review. Epilepsia 39(10):1025\u20131040. https:\/\/doi.org\/10.1111\/j.1528-1157.1998.tb01288.x","journal-title":"Epilepsia"},{"issue":"1","key":"5555_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/S0004-282X2011000100017","volume":"69","author":"H Matushita","year":"2011","unstructured":"Matushita H, Pinto FC, Tognola WA, Andrioli MS (2011) Surgical treatment of neurocysticercosis: clinical study of 190 cases. Arq Neuropsiquiatr 69(1):87\u201393. https:\/\/doi.org\/10.1590\/S0004-282X2011000100017","journal-title":"Arq Neuropsiquiatr"},{"key":"5555_CR17","volume-title":"WHO Expert Consultation on Foodborne Trematode Infections and Taeniasis\/Cysticercosis","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021) WHO expert consultation on foodborne trematode infections and Taeniasis\/Cysticercosis. World Health Organization, Geneva, Switzerland"},{"issue":"1\u20132","key":"5555_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-510X(96)00154-X","volume":"142","author":"OH Del Brutto","year":"1996","unstructured":"Del Brutto OH, Rajshekhar V, White AC Jr et al (1996) Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 142(1\u20132):1\u20136. https:\/\/doi.org\/10.1016\/0022-510X(96)00154-X","journal-title":"J Neurol Sci"},{"issue":"2","key":"5555_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.57.2.177","volume":"57","author":"OH Del Brutto","year":"2001","unstructured":"Del Brutto OH, Rajshekhar V, White AC Jr et al (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57(2):177\u2013183. https:\/\/doi.org\/10.1212\/WNL.57.2.177","journal-title":"Neurology"},{"key":"5555_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jns.2016.11.045","volume":"372","author":"OH Del Brutto","year":"2017","unstructured":"Del Brutto OH, Nash TE, White AC Jr et al (2017) Revised diagnostic criteria for neurocysticercosis. J Neurol Sci 372:202\u2013210. https:\/\/doi.org\/10.1016\/j.jns.2016.11.045","journal-title":"J Neurol Sci"},{"issue":"1","key":"5555_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.idc.2018.10.004","volume":"33","author":"CM Coyle","year":"2019","unstructured":"Coyle CM (2019) Neurocysticercosis: an individualized approach. Infect Dis Clin North Am 33(1):153\u2013168. https:\/\/doi.org\/10.1016\/j.idc.2018.10.004","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"5555_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/19418744211036526","volume":"12","author":"R Pineda-Reyes","year":"2022","unstructured":"Pineda-Reyes R, White AC Jr (2022) Neurocysticercosis diagnosis and management. Neurohospitalist 12(1):92\u2013104. https:\/\/doi.org\/10.1177\/19418744211036526","journal-title":"Neurohospitalist"},{"issue":"8","key":"5555_CR23","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1093\/cid\/cix1084","volume":"66","author":"AC White Jr","year":"2018","unstructured":"White AC Jr, Coyle CM, Rajshekhar V et al (2018) Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 66(8):e49\u2013e75. https:\/\/doi.org\/10.1093\/cid\/cix1084","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5555_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00001432-200310000-00007","volume":"16","author":"HH Garcia","year":"2003","unstructured":"Garcia HH, Gonzalez AE, Gilman RH (2003) Cysticercosis working group in Peru. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis 16(5):411\u2013419. https:\/\/doi.org\/10.1097\/00001432-200310000-00007","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"5555_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0028-3886.65903","volume":"58","author":"G Singh","year":"2010","unstructured":"Singh G, Murthy JMK (2010) Solitary cysticercus granuloma\u2014treatment with albendazole: what is the optimal duration? Neurol India 58(2):159\u2013161. https:\/\/doi.org\/10.4103\/0028-3886.65903","journal-title":"Neurol India"},{"issue":"6","key":"5555_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3171\/foc.2002.12.6.2","volume":"12","author":"J Sotelo","year":"2002","unstructured":"Sotelo J, Del Brutto OH (2002) Review of neurocysticercosis. Neurosurg Focus 12(6):e1. https:\/\/doi.org\/10.3171\/foc.2002.12.6.2","journal-title":"Neurosurg Focus"},{"issue":"4","key":"5555_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1590\/S0004-282X1996000400003","volume":"54","author":"OM Takayanagui","year":"1996","unstructured":"Takayanagui OM, Jardim E, Santos IC et al (1996) Notifica\u00e7\u00e3o compuls\u00f3ria da cisticercose em Ribeir\u00e3o Preto, SP. Arq Neuropsiquiatr 54(4):557\u2013564. https:\/\/doi.org\/10.1590\/S0004-282X1996000400003","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"5555_CR28","first-page":"397","volume":"27","author":"PM Schantz","year":"1993","unstructured":"Schantz PM, Cruz M, Sarti E, Pawlowski Z (1993) Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ 27(4):397\u2013403","journal-title":"Bull Pan Am Health Organ"},{"issue":"3","key":"5555_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2471\/BLT.00.070870","volume":"78","author":"G Roman","year":"2000","unstructured":"Roman G, Sotelo J, Del Brutto O et al (2000) A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ 78(3):399\u2013406. https:\/\/doi.org\/10.2471\/BLT.00.070870","journal-title":"Bull World Health Organ"},{"issue":"10","key":"5555_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199209033271004","volume":"327","author":"PM Schantz","year":"1992","unstructured":"Schantz PM, Moore AC, Munoz JL et al (1992) Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 327(10):692\u2013695. https:\/\/doi.org\/10.1056\/NEJM199209033271004","journal-title":"N Engl J Med"},{"issue":"9","key":"5555_CR31","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1528-1157.1996.tb00045.x","volume":"37","author":"OM Takayanagui","year":"1996","unstructured":"Takayanagui OM, Chimelli L, Silva AA et al (1996) Focal epileptic seizures in neurocysticercosis: treatment with phenytoin and carbamazepine. Epilepsia 37(9):892\u2013896. https:\/\/doi.org\/10.1111\/j.1528-1157.1996.tb00045.x","journal-title":"Epilepsia"},{"issue":"7","key":"5555_CR32","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1212\/01.WNL.0000238514.51747.3A","volume":"67","author":"TE Nash","year":"2006","unstructured":"Nash TE, Singh G, White AC et al (2006) Treatment of neurocysticercosis: current status and future research needs. Neurology 67(7):1120\u20131127. https:\/\/doi.org\/10.1212\/01.WNL.0000238514.51747.3A","journal-title":"Neurology"},{"issue":"3","key":"5555_CR33","doi-asserted-by":"publisher","first-page":"e0005364","DOI":"10.1371\/journal.pntd.0005364","volume":"11","author":"G Debacq","year":"2017","unstructured":"Debacq G, Moyano LM, Garcia HH et al (2017) Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy. PLoS Negl Trop Dis 11(3):e0005364. https:\/\/doi.org\/10.1371\/journal.pntd.0005364","journal-title":"PLoS Negl Trop Dis"},{"issue":"13\u201314","key":"5555_CR34","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ijpara.2021.10.001","volume":"51","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021) WHO informal working group on cysticercosis. Int J Parasitol 51(13\u201314):1231\u20131234. https:\/\/doi.org\/10.1016\/j.ijpara.2021.10.001","journal-title":"Int J Parasitol"},{"issue":"4","key":"5555_CR35","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s15010-023-02021-y","volume":"51","author":"D Stelzle","year":"2023","unstructured":"Stelzle D, Makasi C, Schmidt V, Trevisan C, Van Damme I, Ruether C, Dorny P, Magnussen P, Zulu G, Mwape KE, Bottieau E, Prazeres da Costa C, Prodjinotho UF, Carabin H, Jackson E, Fleury A, Gabri\u00ebl S, Ngowi BJ, Winkler AS (2023) Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. Infection 51(4):1127\u20131139. https:\/\/doi.org\/10.1007\/s15010-023-02021-y","journal-title":"Infection"},{"issue":"8","key":"5555_CR36","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1093\/cid\/cix1084","volume":"66","author":"AC White Jr","year":"2018","unstructured":"White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, Garcia HH, Nash TE (2018) Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 66(8):e49\u2013e75. https:\/\/doi.org\/10.1093\/cid\/cix1084","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5555_CR37","doi-asserted-by":"publisher","first-page":"e00085","DOI":"10.1128\/CMR.00085-19","volume":"33","author":"HH Garcia","year":"2020","unstructured":"Garcia HH, Gonzalez AE, Gilman RH (2020) Taenia solium cysticercosis and its impact in neurological disease. Clin Microbiol Rev 33(3):e00085\u2013e00019. https:\/\/doi.org\/10.1128\/CMR.00085-19","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"5555_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/14787210.2025.2157890","volume":"23","author":"TM de Haes","year":"2025","unstructured":"de Haes TM, Fagundes TP, Takayanagui OM (2025) Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective. Expert Rev Anti Infect Ther 23(8):645\u2013658. https:\/\/doi.org\/10.1080\/14787210.2025.2157890","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"5555_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1473-3099(23)00378-X","volume":"24","author":"D Stelzle","year":"2024","unstructured":"Stelzle D, Makasi CE, Schmidt V, Van Damme I, Trevisan C, Ruether C, Fleury A, Noh J, Handali S, Dorny P, Magnussen P, Zulu G, Mwape KE, Bottieau E, Gabri\u00ebl S, Ngowi BJ, Winkler AS (2024) SOLID collaborators. Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study. Lancet Infect Dis 24(1):98\u2013106. https:\/\/doi.org\/10.1016\/S1473-3099(23)00378-X","journal-title":"Lancet Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05555-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:02:49Z","timestamp":1792281769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05555-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5555"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05555-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}